Abstract
近年来，心脏瓣膜病的介入治疗发展迅猛，各瓣膜领域的循证医学证据逐步积累、器械研发不断推陈出新。我国瓣膜病介入治疗开展相对较晚，但现开展瓣膜病介入治疗的中心和团队快速增多，对各瓣膜领域的研究热点、当前应用与将要面临的困难及挑战应有足够的认识。该文主要总结了2021年主动脉瓣、二尖瓣、三尖瓣、肺动脉瓣4个领域国外发展的新形势及我国的应用现状。.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
